JLJianlong Li

Jianlong Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jianlong Li has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    High-risk profile for perioperative diabetic ketoacidosis in patients undergoing femoral fracture surgery and prevention implications

    by Kaiwei Chen, Boqi Geng, Hongxi Mo, Zuhao Wu, Xiongjie Liang, Xiaozhong Peng, Jiwei Luo, Xingzhan Feng, Jun Xiao, Qinfeng Yang, et al.

    Background/Objective: Diabetic ketoacidosis (DKA) is a severe metabolic complication, but data on perioperative DKA in patients undergoing femoral fracture surgery remain limited. This study aimed to identify risk factors and associated complications of perioperative DKA in this population using the National Inpatient Sample (NIS). Methods: This retrospective study analyzed NIS data from 2016–2022. Patients with traumatic femoral fracture who underwent internal fixation were identified by ICD-10-CM/PCS codes. DKA was identified by ICD-10 codes E08.1, E09.1, E10.1, E11.1, and E13.1. Multivariable models examined demographic, hospital, comorbidity, and complication associations, with FDR correction. Results: Among 337,988 patients, 579 had perioperative DKA. Annual DKA proportions ranged from 0.128% to 0.219%, with an overall increasing trend (Cochran-Armitage p=0.00272). In the comorbidity-domain model, additional diabetes coding (OR=4.074, 95% CI 3.209–5.173) and fluid/electrolyte disorders (OR=3.695, 95% CI 2.982–4.580) were strongly associated with DKA and remained significant after FDR correction. DKA was also associated with sepsis, acute renal failure, shock, pressure ulcer, dialysis, intestinal obstruction, and acute myocardial infarction, as well as longer length of stay and higher hospitalization costs. Conclusions: Perioperative DKA after femoral fracture surgery is uncommon but showed an increasing trend and was strongly associated with diabetes, fluid/electrolyte disorders, severe complications, and greater healthcare utilization. These findings support targeted metabolic monitoring in high-risk patients.

  • Open Access

    Tumoral extracellular vesicles and particles reprogram interstitial macrophages in the lung to promote vascular permeability and metastasis

    by Shani Dror, Inbal Wortzel, Serena Lucotti, Yura Seo, Jianlong Li, Lee Shaashua, Irina Matei, Nancy Boudreau, Haiying Zhang, Maider Astorkia-Amiama, et al.


  • Open Access

    Immunotherapy in bone and soft-tissue tumors: Current advances and future directions

    by Li Fang, Chong Zheng, Haijun Tang, Jian Li, Haohong Zheng, Bin Yang, Xiaodan Li, Jian Wang, Jianlong Li

    Immunotherapy has emerged as a transformative strategy for treating bone and soft-tissue sarcomas, a class of rare, heterogeneous malignancies originating from mesenchymal tissues; however, significant challenges remain. This narrative review summarizes recent advances in sarcoma immunotherapy, covering molecular mechanisms, tumor microenvironment (TME) characteristics, and treatment responses specific to major subtypes such as osteosarcoma, liposarcoma, and synovial sarcoma. Notably, despite being a distinct myeloid neoplasm rather than a sarcoma, systemic mastocytosis is included in this study to identify common therapeutic targets through cross-disease comparisons (e.g., kinase-driven pathways and mechanisms regulating the immunosuppressive TME). Clinical data indicate that single-agent immune checkpoint inhibitors (ICIs) produce limited objective response rates in advanced sarcomas (approximately 16.7%), with significant efficacy disparities across subtypes, ranging from high response rates in alveolar soft part sarcomas to minimal responses in osteosarcomas. Key resistance mechanisms include a suppressive TME dominated by myeloid-derived suppressor cells, low tumor mutational burden, and antigenic heterogeneity. Combination strategies such as ICIs with radiotherapy, tyrosine kinase inhibitors, or anti-angiogenic agents significantly improve outcomes. Emerging cell therapies such as chimeric antigen receptor T-cell, T-cell receptor–engineered, and tumor-infiltrating lymphocyte therapies, combined with neoantigen vaccines and nanotechnology-driven delivery systems, demonstrate potential in reshaping the TME and overcoming immune escape. Biomarkers, including programmed death-ligand 1 expression, tertiary lymphoid structures, and immune gene profiles, hold prognostic value but require further validation. Future research should prioritize tissue-specific trial designs, combined TME remodeling regimens, and biomarker-guided personalized therapies to effectively convert “cold” sarcomas into immunotherapy-responsive malignancies.

  • Open Access

    Machine learning-enhanced discovery of a basement membrane-related gene signature in glioblastoma via single-cell and Spatial transcriptomics

    by Ziyuan Liu, Yufan Yang, Haiting Fang, Miaoxi Han, Panpan Qi, Yiqi Fan, Jianlong Li, Shuai He, Lijie Wang

    The complex invasiveness and heterogeneity of glioblastoma multiforme (GBM) hinder the complete eradication of the tumor. The invasion of the basement membrane (BM) occurs before the spread to the meninges and the metastasis of glioma cells, increasing the recurrence rate of the disease, leading to poor patient prognosis. In this study, four cohorts of GBM patients were aggregated to confirm the BM candidate genes through binary classification machine learning (ML). We delineated their features and developed a novel BM related genes (BMRGs) risk model through ML combinations, and compared it with previous models. Concurrently, the immune attributes of high and low-risk groups were analyzed using the immune infiltration algorithm encompassing CIBERSORT, xCell, and ssGSEA. Novel immunotherapeutic and chemotherapeutic strategies were proposed based on the assessment of immune treatment evaluation tools, TIDE and IRnet, and drug sensitivity analysis. Lastly, single-cell and spatial transcriptomics were utilized to unearth the properties of tumor cells with high BMRGs expression which were then verified via independent cohorts incorporating 42 samples from 17 patients. In accordance with ML combinations, four BMRGs provided the foundation for the predictive model, serving to categorize patients into groups of high and low risk. It was observed that increased risk scores correlated with diminished overall survival rates. Immune infiltration analysis revealed that high-risk group was characterized by a heightened infiltration of M2-like macrophages and a decrease in CD8 T cells. Concurrently, it was noted that high-risk group had reduced immunotherapy benefit scores. A drug sensitivity analysis revealed that high-risk group exhibited greater sensitivity towards five drugs. Furthermore, single-cell RNA sequencing (scRNA-seq) analyses discerned tumor cells with a high BMRGs score demonstrated more effective intercellular communication. The concluding observations revealed that BMRGs have enhanced expression and significant co-localization within GBM samples. This study elucidates a direct molecular correlation between GBM and BM, establishes a BMRGs signature risk model, and explores their interconnectivity. The findings offer pivotal insights into the clinical outcomes, therapeutic responses, and potential treatment strategies for GBM. Machine learning combinations depicted the characteristics of BM-related genes and established a BMRGs risk model. The BMRGs signature model shows good accuracy in the prognosis prediction of GBM patients. Patients in the high-risk group demonstrate reduced sensitivity to immunotherapy and heightened sensitivity to selected chemotherapy drugs. GBM cells with higher BMRGs expression have stronger communication functions. Spatial transcriptomics and independent cohort validation revealed that FOS regulates the expression of ADM, PLOD3 and AEBP1.


  • Open Access

    GSCs differentiation model-informed nanotherapy: dual-functional brain-targeting liposomes with iRGD modification for co-delivery of osimertinib and bortezomib to combat radioresistant glioblastoma

    by Cuiying Xie, Jieyi Wu, Han Yang, Ancheng Gu, Wanwen Cao, Xiangcao Yao, Zhiyong Li, Yuchun Niu, Jianlong Li, Zhongyuan Xu, et al.

    Radiation resistance in glioblastoma (GBM) poses a persistent clinical hurdle, driven in part by hyperactivated EGFR and NF-κB signaling. To recapitulate post-radiation tumor recurrence, we engineered radioresistant glioblastoma stem cells (GSCs) from U87-derived GSCs via 13 cycles of 5Gy irradiation (IR), yielding differentiated radioresistant progeny cells (Diff) that mimic the aggressive phenotype of recurrent GBM. Integrative analysis of RNA sequencing data from parental U87 cells, GSCs, and Diff cells—along with the TCGA database—identified coordinated EGFR and NF-κB (RelA/p65) signaling as central mediators of therapeutic resistance. Leveraging this insight, we designed iRGD-modified liposomes (iRGD-OB-LP) for targeted co-delivery of Osimertinib (EGFR inhibitor) and Bortezomib (NF-κB suppressor). These liposomes exhibited enhanced tumor penetration, sustained release kinetics, and dual pathway inhibition, which collectively prolonged radiation-induced DNA damage, attenuated cancer stemness, and amplified apoptotic cell death. In vivo, iRGD-OB-LP achieved tumor-specific biodistribution, synergized with radiotherapy to suppress tumor progression, and extended survival without systemic toxicity. By bridging a radioresistant GBM model with mechanism-driven nanotherapy, this work provides a translatable blueprint for dismantling therapeutic resistance in GBM through precision multi-targeting.


  • Open Access

    Large-scale bulk and single-cell RNA sequencing combined with machine learning reveals glioblastoma-associated neutrophil heterogeneity and establishes a VEGFA+ neutrophil prognostic model

    by Yufan Yang, Ziyuan Liu, Zhongliang Wang, Xiang Fu, Zhiyong Li, Jianlong Li, Zhongyuan Xu, Bohong Cen

    Neutrophils play a key role in the tumor microenvironment (TME); however, their functions in glioblastoma (GBM) are overlooked and insufficiently studied. A detailed analysis of GBM-associated neutrophil (GBMAN) subpopulations may offer new insights and opportunities for GBM immunotherapy. We analyzed single-cell RNA sequencing (scRNA-seq) data from 127 isocitrate dehydrogenase (IDH) wild-type GBM samples to characterize the GBMAN subgroups, emphasizing developmental trajectories, cellular communication, and transcriptional networks. We implemented 117 machine learning combinations to develop a novel risk model and compared its performance to existing glioma models. Furthermore, we assessed the biological and molecular features of the GBMAN subgroups in patients. From integrated large-scale scRNA-seq data (498,747 cells), we identified 5,032 neutrophils and classified them into four distinct subtypes. VEGFA+GBMAN exhibited reduced inflammatory response characteristics and a tendency to interact with stromal cells. Furthermore, these subpopulations exhibited significant differences in transcriptional regulation. We also developed a risk model termed the “VEGFA+neutrophil-related signature” (VNRS) using machine learning methods. The VNRS model showed higher accuracy than previously published risk models and was an independent prognostic factor. Additionally, we observed significant differences in immunotherapy responses, TME interactions, and chemotherapy efficacy between high-risk and low-risk VNRS score groups. Our study highlights the critical role of neutrophils in the TME of GBM, allowing for a better understanding of the composition and characteristics of GBMAN. The developed VNRS model serves as an effective tool for evaluating the risk and guiding clinical treatment strategies for GBM. Not applicable. Large-scale scRNA-seq of GBM identified four neutrophil subtypes and characterized their molecular landscape. Trajectory analysis identified the developmental process of MNDA+GBMAN into VEGFA+GBMAN. VEGFA+GBMAN exhibits significant immunosuppressive and hypoxic characteristics. A VNRS prognostic model based on VEGFA+GBMAN was proposed using 117 machine learning combinations. The VNRS model demonstrates significant superiority and can accurately predict patient characteristics.


  • Open Access

    The role of melanoma-derived exosomes in metastasis: Challenges and opportunities

    by Manting Luo, Huirong Hong, Yufan Yang, Ziyuan Liu, Zhiheng Zhou, Tao Ren, Guofen Chen, Jun Xiao, Bohong Cen, Jian Wang, et al.

    Melanoma, a highly aggressive skin cancer, is characterized by its strong metastatic potential and resistance to standard treatments. Recent cancer research has emphasized the significance of exosomes, a type of extracellular vesicle and particle, in mediating cell-to-cell communication and driving tumor progression. Melanoma-derived exosomes contribute to metastasis by facilitating immune evasion, modulating the tumor microenvironment, and inducing epithelial-to-mesenchymal transition. The exosomal cargos, including nucleic acids (DNA, microRNA, long noncoding RNA, and circular RNA), proteins, lipids, and other biomolecules, play critical roles in reprogramming recipient cells to support tumor growth and spread. These exosomes also aid in forming pre-metastatic niches by transferring pro-inflammatory cytokines, extracellular matrix remodeling enzymes, and angiogenic factors to distant organs, preparing these sites for tumor colonization. Furthermore, tumor-derived exosomes promote therapy resistance by delivering drug-resistant molecular signatures, which diminish treatment efficacy. This emerging evidence highlights the therapeutic potential of exosome-based strategies, including inhibitors of exosome biogenesis and uptake or the use of engineered exosomes for targeted drug delivery. Advances in precision medicine also facilitate the use of exosome-derived molecular signatures in early-stage diagnosis and treatment monitoring through liquid biopsy. However, clinical translation remains challenging due to cargo heterogeneity, lack of standardized isolation methods, and potential off-target effects in exosome-based therapies. Addressing these challenges could lead to more effective therapies and better patient outcomes. This review synthesizes current knowledge on the biogenesis, composition, and functional roles of tumor-derived exosomes in metastasis, alongside their potential applications as biomarkers and therapeutic strategies. Deciphering exosomal dynamics in melanoma may open new avenues for advanced diagnostics and treatments.


  • Open Access

    Synovial sarcoma extracellular vesicles induce fatty liver

    by Tao Ren, Zhiheng Zhou, Huirong Hong, Bohong Cen, Jun Xiao, Guofen Chen, Yang Zhang, Jianlong Li

    Synovial sarcoma leads to pathological changes in multiple organs. To investigate the mechanism by which synovial sarcoma induces fatty liver through extracellular vesicles (EVs), the synovial sarcoma SW-982 cells were orthotopically implanted, or SW-982 derived EVs were extracted and used to "educate" nude mice. Liver tissues were then subjected to H&E and Oil-Red O (ORO) staining, and qPCR analysis. EVs were characterized using TEM and Nanosight. The bio-distribution of EVs in vivo was verified using the fluorescent dye Burgundy staining, followed by Odyssey imaging. Immunofluorescence (IF) and flow cytometry were used to confirm cellular uptake of EVs. Rab27a knockdown (KD) efficiency was validated by Western blot, and lipid droplet deposition in the liver from mice bearing with SW-982-Rab27a-KD cells was observed by staining with ORO. After three weeks of orthotopic implantation of SW-982 cells in nude mice, qPCR and H&E showed no tumor metastasis in liver tissues, while ORO staining revealed lipid deposition in the liver, and EVs diameters were confirmed by Nanosight and TEM to be approximately 141 nm in size. In vivo, EVs were taken up by liver Kupffer cells (KCs). After "educating" nude mice with EVs, lipid deposition in the liver was observed. In rescue experiments, Rab27a knockdown reduced EV secretion from the tumor, and KC inactivation led to decreased lipid deposition in the liver. It is shown that synovial sarcoma EVs mediate fatty liver through Kupffer cells.


  • Open Access

    Single-cell multi-omics analysis reveals candidate therapeutic drugs and key transcription factor specifically for the mesenchymal subtype of glioblastoma

    by Yufan Yang, Ziyuan Liu, Yerong Wei, Shuai He, Ancheng Gu, Zhiyong Li, Jianlong Li, Zhongyuan Xu, Bohong Cen

    The inherent heterogeneity of tumor cells impedes the development of targeted therapies for specific glioblastoma (GBM) subtypes. This study aims to investigate the mesenchymal subtype of GBM to uncover detailed characteristics, potential therapeutic strategies, and improve precision treatment for GBM patients. We integrated single-cell RNA sequencing (scRNA-seq), single-nucleus assay for transposase-accessible chromatin sequencing (snATAC-seq), and bulk RNA sequencing datasets to identify core gene modules, candidate therapeutic drugs, and key transcription factors specific to mesenchymal subtype GBM tumor cells which we validated in vitro and human samples. Our analysis encompassed a heterogeneous single-cell landscape of 55,845 cells from tumor and adjacent normal tissues, focusing on the mesenchymal subtype’s adverse prognosis and its association with hypoxia. We identified a core gene module composed of 38 genes and, through pharmacogenomic analysis, found that Trametinib and Dasatinib exhibit increased effectiveness against mesenchymal subtype GBM cells. Furthermore, by incorporating snATAC-seq data, we delineated a crucial regulatory network and pinpointed the key transcription factor CEBPG. Our research has highlighted the strong link between the mesenchymal-like (MES-like) properties of GBM and hypoxia, providing valuable insights into candidate drugs and pivotal targets for precision treatment of the mesenchymal subtype. Graphical Abstract